Core Laboratories N.V.
CLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $32,153 | $37,025 | $19,658 | $20,219 |
| Dep. & Amort. | $14,953 | $15,784 | $17,161 | $18,516 |
| Deferred Tax | $674 | -$10,811 | $433 | $6,012 |
| Stock-Based Comp. | $3,755 | $13,971 | $7,756 | $19,093 |
| Change in WC | $7,879 | -$28,772 | -$25,019 | -$24,253 |
| Other Non-Cash | -$3,026 | -$2,408 | $4,967 | -$3,008 |
| Operating Cash Flow | $56,388 | $24,789 | $24,956 | $36,579 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,028 | -$10,579 | -$10,216 | -$13,539 |
| Net Acquisitions | $0 | $0 | $240 | $873 |
| Inv. Purchases | $0 | $0 | $0 | $13,539 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $726 |
| Other Inv. Act. | $6,634 | $3,927 | $6,120 | -$11,822 |
| Investing Cash Flow | -$6,394 | -$6,652 | -$3,856 | -$10,223 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$38,000 | -$9,000 | -$15,000 | -$71,000 |
| Stock Issued | $0 | $0 | $0 | $60,000 |
| Stock Repurch. | -$5,306 | -$2,202 | -$3,903 | -$8,256 |
| Dividends Paid | -$1,876 | -$1,868 | -$1,853 | -$1,834 |
| Other Fin. Act. | -$775 | -$5,375 | -$2,619 | -$1,369 |
| Financing Cash Flow | -$45,957 | -$18,445 | -$23,375 | -$22,459 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,037 | -$308 | -$2,275 | $3,897 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,120 | $15,428 | $17,703 | $13,806 |
| End Cash | $19,157 | $15,120 | $15,428 | $17,703 |
| Free Cash Flow | $43,360 | $14,210 | $14,740 | $23,040 |